Consistently, our study demonstrated that the expression of Keap1/ Nrf2-ARE was significantly down-regulated in AP mice, and their downregulation can be reversed by formononetin administration, which further confirms the anti-oxidative function of formononetin in the context of AP. The gene discussed is KEAP1; the disease is alkaline phosphatase measurement.